Fig. 4From: The efficacy and safety of exercise regimens to mitigate chemotherapy cardiotoxicity: a systematic review and meta-analysis of randomized controlled trialsForest plots of the secondary efficacy outcomes, (1: Left ventricular ejection fraction (LVEF) change, 2: Global longitudinal strain (GLS) change, 3: Stroke volume (SV) change, 4: Left ventricular end-diastolic volume (LVEDV) change, 5: Left ventricular end-systolic volume (LVESV) change, 6: E/A ratio change, and 7: Cardiac output (CO) change), MD: mean difference, CI: confidence intervalBack to article page